About Arava
Arava helps improve RA symptoms More than 960,000 people worldwide have been prescribed Arava (leflunomide) for the treatment of rheumatoid arthritis (RA).

Arava, a medication classified as a disease-modifying antirheumatic drug (DMARD), helps improve RA symptoms such as joint swelling and tenderness. But unlike many symptom relievers that only help relieve pain and swelling, Arava actually helps slow the progression of joint damage caused by RA. So, while there is no cure for RA, Arava may help prevent RA from getting worse.

Clinically Proven Results

How do we know Arava helps improve RA symptoms and slow the progression of RA? Results from clinical studies prove the effectiveness of Arava.

Study results show that in adult RA patients, Arava significantly reduces pain and morning stiffness in the joints. After 5 years of treatment with Arava, researchers noted a considerable improvement in study patients' RA symptoms.

Study results also show Arava improves patients' physical function. After 1 year of treatment, researchers noted an improvement in study patients' ability to perform daily tasks such as eating, dressing, bathing and walking. Patients who continued taking Arava for a second year maintained improved physical function.

Study results also prove the ability of Arava to slow the progression of RA. After 6 months of treatment, Arava already had started to slow the rate of bone and cartilage damage in study patients' joints. After 1 year, patients showed very little progression of joint damage. And after 2 years, X rays showed that few patients in the study had newly damaged joints during the second year of treatment.

Arava Is Convenient

In addition to being effective in decreasing pain and swelling while helping to slow the progression of RA, Arava is easy to take. Arava comes in a convenient once-daily tablet that you may take with or without meals.

Click here for important safety information about Arava.

If you need more information about Arava, please click here.


Site Map | Contact Us

© 2005 Aventis Pharmaceuticals Inc. All rights reserved.
Legal Disclaimer Information and Privacy Policy
Questions or Comments? Click here to contact us.

The sanofi-aventis Group conducts business in the U.S. through its affiliate
Aventis Pharmaceuticals Inc.
This site is intended for use by U.S. residents only.

USA.LEF.05.09.03 Last Update: September 2005